Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective March 4, 2013, Keith Bley, Ph.D., formally joined NovaBay Pharmaceuticals, Inc. as Senior Vice President for Product Development. Dr. Bley has more than 20 years experience in the pharmaceutical industry with increasingly responsible management positions in research and product development.

Prior to his arrival at NovaBay, he worked as consultant to various pharmaceutical companies in the Bay Area, assisting these companies with a wide range of drug development activities and was the Senior Vice President for Nonclinical Research and Development at NeurogesX, Inc. for over 10 years.

Prior to NeurogesX, Dr. Bley worked as Research Manager for Roche Pharmaceuticals after working at Syntex Corporation.

Dr. Bley received his Ph.D. in Cellular and Molecular Physiology from Yale University. He also earned a masters degree in philosophy from Columbia University and his Bachelors in Philosophy (with Honors) from the Catholic University of America in Washington D.C.

---